Virtu KCG Holdings’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Virtu KCG Holdings’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$39K	Buy	+7	New	+$38.4K	﹤0.01%	2641
2017 Q1	–	Sell	-4	Closed	-$29K	–	3161
2016 Q4	$29K	Buy	+4	New	+$28K	﹤0.01%	3185
2016 Q3	–	Sell	-9	Closed	-$70K	–	3088
2016 Q2	$70K	Buy	9 +4	+80%	+$33.8K	﹤0.01%	2610
2016 Q1	$44K	Sell	5 -1	-17%	-$6.93K	﹤0.01%	2488
2015 Q4	$52K	Buy	6 +1	+20%	+$10.1K	﹤0.01%	3148
2015 Q3	$61K	Sell	5 -2	-29%	-$13.4K	﹤0.01%	2956
2015 Q2	$48K	Sell	7 -10	-59%	-$70K	﹤0.01%	3074
2015 Q1	$112K	Buy	+17	New	+$204K	﹤0.01%	2623

Other funds holding CANF

TAM

Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Virtu KCG Holdings's CANF Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2017: 7 shares worth $39K. The stake represents ﹤0.01% of the portfolio and ranks #2641 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in CANF as recently as Q4 2016.

Virtu KCG Holdings first reported a position in CANF in Q1 2015 and has held it in 8 quarters since. The position peaked at $112K in Q1 2015. 6 funds tracked by Wall St. Rank hold CANF as of Q2 2017.

Virtu KCG Holdings held 7 shares of Can-Fite BioPharma American Depositary Shares worth $39K as of Q2 2017.
Can-Fite BioPharma American Depositary Shares was a new Virtu KCG Holdings position in Q2 2017.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2641 holding.
Virtu KCG Holdings first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2015 and has held it in 8 quarters since.
Virtu KCG Holdings's Can-Fite BioPharma American Depositary Shares position peaked at $112K in Q1 2015.
6 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.